The Valley Desk

Clinical trial reportClinical cancer research : an official journal of the American Association for Cancer ResearchPublished

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Coriell Institute for Medical Research, Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical cancer research : an official journal of the American Association for Cancer Research
Published
Subject terms
Humans; Carcinoma, Transitional Cell; Neoplasm Recurrence, Local; Azacitidine; Antineoplastic Agents; Urinary Bladder Neoplasms; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Immune Checkpoint Inhibitors
PubMed ID
36928921
PubMed Central ID
PMC10233355
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal